JP2010505836A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010505836A5 JP2010505836A5 JP2009531440A JP2009531440A JP2010505836A5 JP 2010505836 A5 JP2010505836 A5 JP 2010505836A5 JP 2009531440 A JP2009531440 A JP 2009531440A JP 2009531440 A JP2009531440 A JP 2009531440A JP 2010505836 A5 JP2010505836 A5 JP 2010505836A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- disease
- radiation
- cancer
- renal
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 0 CC(C(*)C[C@](CC1)C[C@@](*)(C[C@](*)([C@]2[C@@](C)O3)C3=O)[C@]1([C@](C)C1)[C@@]21C=C[C@]1C(*)=CC(c2cccc(F)c2)=CC1)C(OCC(*)O)=O Chemical compound CC(C(*)C[C@](CC1)C[C@@](*)(C[C@](*)([C@]2[C@@](C)O3)C3=O)[C@]1([C@](C)C1)[C@@]21C=C[C@]1C(*)=CC(c2cccc(F)c2)=CC1)C(OCC(*)O)=O 0.000 description 3
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US84928406P | 2006-10-04 | 2006-10-04 | |
| PCT/US2007/021259 WO2008060372A2 (en) | 2006-10-04 | 2007-10-02 | Thrombin receptor antagonists based on the modified tricyclic unit of himbacine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010505836A JP2010505836A (ja) | 2010-02-25 |
| JP2010505836A5 true JP2010505836A5 (enExample) | 2010-04-22 |
Family
ID=39284222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009531440A Withdrawn JP2010505836A (ja) | 2006-10-04 | 2007-10-02 | ヒンバシンの修飾された三環単位に基づいたトロンビン受容体アンタゴニスト |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20080085923A1 (enExample) |
| EP (1) | EP2078012A2 (enExample) |
| JP (1) | JP2010505836A (enExample) |
| KR (1) | KR20090058583A (enExample) |
| CN (1) | CN101553484A (enExample) |
| AR (1) | AR063095A1 (enExample) |
| AU (1) | AU2007320029A1 (enExample) |
| CA (1) | CA2666903A1 (enExample) |
| IL (1) | IL198011A0 (enExample) |
| MX (1) | MX2009003758A (enExample) |
| TW (1) | TW200823206A (enExample) |
| WO (1) | WO2008060372A2 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8227412B2 (en) * | 2007-03-29 | 2012-07-24 | Tsopanoglou Nikos E | Bioactive parstatin peptides and methods of use |
| MX2011012861A (es) * | 2009-06-04 | 2012-01-25 | Schering Corp | Metabolito activo de un antagonista de receptor de trombina. |
| WO2011041217A1 (en) * | 2009-10-02 | 2011-04-07 | Schering Corporation | The use of a par-1 antagonist in combination with a p2y12adp receptor antagonist for inhibition of thrombosis |
| CN105777681B (zh) * | 2014-12-17 | 2019-03-01 | 博瑞生物医药（苏州）股份有限公司 | 喜巴辛类似物及其中间体的制备方法 |
| JPWO2016114386A1 (ja) * | 2015-01-15 | 2017-10-19 | 国立研究開発法人国立精神・神経医療研究センター | 進行型免疫性脱髄疾患治療剤 |
| CN105985303B (zh) * | 2015-02-13 | 2020-08-14 | 上海彩迩文生化科技有限公司 | 抗凝血剂的制备方法、中间体及其制备方法 |
| CN106866450B (zh) * | 2017-01-13 | 2019-01-11 | 阜阳欣奕华材料科技有限公司 | 硫酸沃拉帕沙中间体的制备方法 |
| CN110483455A (zh) * | 2019-09-29 | 2019-11-22 | 天津力生制药股份有限公司 | 一种硫酸沃拉帕沙中间体醛基物的合成方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6063847A (en) * | 1997-11-25 | 2000-05-16 | Schering Corporation | Thrombin receptor antagonists |
| MY130642A (en) * | 2000-06-15 | 2007-07-31 | Schering Corp | Nor-seco himbacine derivatives useful as thrombin receptor antagonists |
| MXPA04003610A (es) * | 2001-10-18 | 2004-07-27 | Schering Corp | Analogos de himbacina como antagonistas del receptor de trombina. |
| ATE378330T1 (de) * | 2002-04-16 | 2007-11-15 | Schering Corp | Trizyklische thrombin rezeptor antagonisten |
-
2007
- 2007-10-02 AU AU2007320029A patent/AU2007320029A1/en not_active Abandoned
- 2007-10-02 EP EP07867200A patent/EP2078012A2/en not_active Withdrawn
- 2007-10-02 CN CNA2007800433580A patent/CN101553484A/zh active Pending
- 2007-10-02 KR KR1020097008460A patent/KR20090058583A/ko not_active Withdrawn
- 2007-10-02 AR ARP070104357A patent/AR063095A1/es not_active Application Discontinuation
- 2007-10-02 WO PCT/US2007/021259 patent/WO2008060372A2/en not_active Ceased
- 2007-10-02 MX MX2009003758A patent/MX2009003758A/es not_active Application Discontinuation
- 2007-10-02 CA CA002666903A patent/CA2666903A1/en not_active Abandoned
- 2007-10-02 US US11/866,012 patent/US20080085923A1/en not_active Abandoned
- 2007-10-02 JP JP2009531440A patent/JP2010505836A/ja not_active Withdrawn
- 2007-10-03 TW TW096137099A patent/TW200823206A/zh unknown
-
2009
- 2009-04-05 IL IL198011A patent/IL198011A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505836A5 (enExample) | ||
| FI4034104T3 (fi) | Menetelmiä ja yhdisteitä mutantin p53-toiminnan palauttamiseksi | |
| JP2009521399A5 (enExample) | ||
| JP7577682B2 (ja) | ガレクチン－３の低分子阻害剤 | |
| CA2540163A1 (en) | Thrombin receptor antagonists | |
| AR080792A1 (es) | Compuesto de 1-acetil-indol, composicion farmaceutica que lo comprende y su uso para preparar un medicamento util para la inhibicion de la actividad de perk y para tratar o reducir la gravedad del cancer y otras dolencias. | |
| CA2868081C (en) | Inhibition of mcl-1 and/or bfl-1/a1 | |
| JP2016539121A5 (enExample) | ||
| JP2010509286A5 (enExample) | ||
| JP2010509284A5 (enExample) | ||
| JP2011126896A5 (enExample) | ||
| JP2018529779A5 (enExample) | ||
| MY140756A (en) | Fused azole-pyrimidine derivatives | |
| RU2018142605A (ru) | Селективный ингибитор фосфатидилинозитол-3-киназы-гамма | |
| WO2013048214A3 (en) | Novel heterocyclic derivatives and their uses | |
| WO2006004658A3 (en) | Furanopyrimidines | |
| JP2017520613A5 (enExample) | ||
| IL190835A0 (en) | Sulfonamide derivatives, their preparation and use | |
| NZ605690A (en) | Oxadiazole inhibitors of leukotriene production | |
| JP2017522350A5 (enExample) | ||
| JP2018515556A5 (enExample) | ||
| EP2140882A4 (en) | MEDICINE FOR THE TREATMENT OF LUNG DISEASES | |
| UA101348C2 (ru) | 1,2,4-оксадиазольные соединения для лечения аутоиммунных заболеваний | |
| JP2016513704A5 (enExample) | ||
| RU2014142057A (ru) | Комплексная терапия |